Literature DB >> 30839092

Reply to Raoult and Rolain, and to Echols and Tillotson.

Sameer S Kadri1, Robert L Danner1.   

Abstract

Mesh：

Year:  2019        PMID： 30839092      PMCID： PMC6792094          DOI： 10.1093/cid/ciz186

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  10 in total

1.  Difficult to Treat: Do We Need a New Definition?

Authors:  Roger M Echols; Glenn S Tillotson
Journal:  Clin Infect Dis       Date:  2019-10-15       Impact factor: 9.079

2.  The Paradigm of the Shadoks and Antibiotic Resistance.

Authors:  Didier Raoult; Jean-Marc Rolain
Journal:  Clin Infect Dis       Date:  2019-10-15       Impact factor: 9.079

3.  Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: results from the SENTRY Antimicrobial Surveillance Program, 2009-2012.

Authors:  Helio S Sader; David J Farrell; Robert K Flamm; Ronald N Jones
Journal:  Int J Antimicrob Agents       Date:  2014-02-07       Impact factor: 5.283

4.  The Infectious Diseases Society of America's 10 × '20 Initiative (10 New Systemic Antibacterial Agents US Food and Drug Administration Approved by 2020): Is 20 × '20 a Possibility?

Authors:  George H Talbot; Amanda Jezek; Barbara E Murray; Ronald N Jones; Richard H Ebright; Gerard J Nau; Keith A Rodvold; Jason G Newland; Helen W Boucher
Journal:  Clin Infect Dis       Date:  2019-06-18       Impact factor: 9.079

5.  Evaluating the Clinical Burden and Mortality Attributable to Antibiotic Resistance: The Disparity of Empirical Data and Simple Model Estimations.

Authors:  Cédric Abat; Jean-Marc Rolain; Grégory Dubourg; Pierre-Edouard Fournier; Hervé Chaudet; Didier Raoult
Journal:  Clin Infect Dis       Date:  2017-08-15       Impact factor: 9.079

6.  Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents.

Authors:  Sameer S Kadri; Jennifer Adjemian; Yi Ling Lai; Alicen B Spaulding; Emily Ricotta; D Rebecca Prevots; Tara N Palmore; Chanu Rhee; Michael Klompas; John P Dekker; John H Powers; Anthony F Suffredini; David C Hooper; Scott Fridkin; Robert L Danner
Journal:  Clin Infect Dis       Date:  2018-11-28       Impact factor: 9.079

7.  Attributable mortality from extensively drug-resistant gram-negative infections using propensity-matched tracer antibiotic algorithms.

Authors:  Sameer S Kadri; Jeffrey R Strich; Bruce J Swihart; Samuel Hohmann; John P Dekker; Tara Palmore; Stephanie Bonne; Bradley Freeman; Jillian Raybould; Nirav G Shah; Devang Patel; Jennifer Husson; Mitchell D Jacobs; Lan Duong; Dean Follmann; David C Hooper; Joseph Timpone; Robert L Danner
Journal:  Am J Infect Control       Date:  2019-02-27       Impact factor: 2.918

8.  Short-Course Adjunctive Gentamicin as Empirical Therapy in Patients With Severe Sepsis and Septic Shock: A Prospective Observational Cohort Study.

Authors:  David S Y Ong; Jos F Frencken; Peter M C Klein Klouwenberg; Nicole Juffermans; Tom van der Poll; Marc J M Bonten; Olaf L Cremer
Journal:  Clin Infect Dis       Date:  2017-06-15       Impact factor: 9.079

9.  Antimicrobial Resistance.

Authors:  Hilary D Marston; Dennis M Dixon; Jane M Knisely; Tara N Palmore; Anthony S Fauci
Journal:  JAMA       Date:  2016-09-20       Impact factor: 56.272

10.  Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis.

Authors:  Alessandro Cassini; Liselotte Diaz Högberg; Diamantis Plachouras; Annalisa Quattrocchi; Ana Hoxha; Gunnar Skov Simonsen; Mélanie Colomb-Cotinat; Mirjam E Kretzschmar; Brecht Devleesschauwer; Michele Cecchini; Driss Ait Ouakrim; Tiago Cravo Oliveira; Marc J Struelens; Carl Suetens; Dominique L Monnet
Journal:  Lancet Infect Dis       Date:  2018-11-05       Impact factor: 25.071
  10 in total
  1 in total

1.  Prognostic Utility of the New Definition of Difficult-to-Treat Resistance Among Patients With Gram-Negative Bloodstream Infections.

Authors:  Maddalena Giannella; Linda Bussini; Renato Pascale; Michele Bartoletti; Matteo Malagrinò; Livia Pancaldi; Alice Toschi; Giuseppe Ferraro; Lorenzo Marconi; Simone Ambretti; Russell Lewis; Pierluigi Viale
Journal:  Open Forum Infect Dis       Date:  2019-12-12       Impact factor: 3.835
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.